ATE73335T1 - Pharmazeutische produkte. - Google Patents

Pharmazeutische produkte.

Info

Publication number
ATE73335T1
ATE73335T1 AT89305829T AT89305829T ATE73335T1 AT E73335 T1 ATE73335 T1 AT E73335T1 AT 89305829 T AT89305829 T AT 89305829T AT 89305829 T AT89305829 T AT 89305829T AT E73335 T1 ATE73335 T1 AT E73335T1
Authority
AT
Austria
Prior art keywords
hydrogen
nrr
azido
pharmaceutical products
synergistic
Prior art date
Application number
AT89305829T
Other languages
English (en)
Inventor
Robert Vince
William M Shannon
Original Assignee
Univ Minnesota
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Southern Res Inst filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE73335T1 publication Critical patent/ATE73335T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT89305829T 1988-06-10 1989-06-09 Pharmazeutische produkte. ATE73335T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20516388A 1988-06-10 1988-06-10
EP89305829A EP0346132B1 (de) 1988-06-10 1989-06-09 Pharmazeutische Produkte

Publications (1)

Publication Number Publication Date
ATE73335T1 true ATE73335T1 (de) 1992-03-15

Family

ID=22761073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89305829T ATE73335T1 (de) 1988-06-10 1989-06-09 Pharmazeutische produkte.

Country Status (9)

Country Link
EP (1) EP0346132B1 (de)
JP (1) JPH0291022A (de)
AT (1) ATE73335T1 (de)
AU (1) AU627188B2 (de)
DE (1) DE68900961D1 (de)
DK (1) DK284189A (de)
GR (1) GR3004628T3 (de)
NZ (1) NZ229453A (de)
ZA (1) ZA894392B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
IT1229531B (it) * 1988-01-20 1991-09-04 Univ Minnesota Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
GB2243609B (en) * 1988-01-20 1992-03-11 Univ Minnesota Dideoxydidehydrocarbocyclic pyrimidines
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
CA2278158A1 (en) * 1997-01-14 1998-07-16 Guangyi Wang Cytokine related treatments of disease
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
NZ504994A (en) * 1997-12-22 2002-10-25 Schering Corp Orally administrable rapidly dissolving solid ribavirin dosage forms
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
JP5230052B2 (ja) 2000-05-26 2013-07-10 イデニクス（ケイマン）リミテツド フラビウイルスおよびペスチウイルス治療のための方法および組成物
KR20050013628A (ko) * 2002-06-27 2005-02-04 메디비르 아베 아바카비르와 알로부딘의 공동상승 상호작용
CA2506129C (en) 2002-11-15 2015-02-17 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
WO2006122003A2 (en) * 2005-05-05 2006-11-16 Ardea Biosciences, Inc. Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
WO2006137447A1 (ja) * 2005-06-24 2006-12-28 Yamasa Corporation シュードウリジン保護体の安定結晶

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4362729A (en) * 1980-06-23 1982-12-07 The Regents Of The University Of Minnesota Alkoxyalkanoate esters of cyclaradine
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
DE58902899D1 (de) * 1988-12-14 1993-01-14 Ciba Geigy Ag 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Also Published As

Publication number Publication date
GR3004628T3 (de) 1993-04-28
EP0346132A1 (de) 1989-12-13
DK284189D0 (da) 1989-06-09
AU3627289A (en) 1989-12-14
AU627188B2 (en) 1992-08-20
DK284189A (da) 1989-12-11
NZ229453A (en) 1991-08-27
DE68900961D1 (de) 1992-04-16
ZA894392B (en) 1990-08-29
JPH0291022A (ja) 1990-03-30
EP0346132B1 (de) 1992-03-11

Similar Documents

Publication Publication Date Title
DE68900961D1 (de) Pharmazeutische produkte.
EE02995B1 (et) 1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks
DK0513917T3 (da) Antivirale kombinationer indeholdende nukleosidanaloger
RU95109100A (ru) Производные ксантина, смесь их изомеров или отдельные изомеры и их фармакологически переносимые соли и фармацевтическая композиция с антагонистической в отношении аденозина активностью на их основе
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
ATE81653T1 (de) Dideoxydidehydrocarbocyclische nukleoside.
NO923721L (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
DE68900760D1 (de) Virushemmende nukleosidmischung.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DK0388049T3 (da) Penciclovirderivater til behandling af hepatitis B infektioner
ES2134259T3 (es) Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos.
NO305551B1 (no) Nitroksyalkylamidderivater og farmas°ytiske preparater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee